Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott Patterson

Showing results (11-20 of 61) with videos related to

Pageof 7
Sort By:
Human Vaccines & Immunotherapeutics|February 3, 2018
Modeling excess zeroes in an integrated analysis of vaccine safetyRoger Maansson, David Radley, Qin Jiang, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 1, 2013
Combination of lamivudine and adefovir without hepatitis B immune globulin is safe and effective prophylaxis against hepatitis B virus recurrence in hepatitis B surface antigen-positive liver transplant candidatesEdward J Gane, Scott Patterson, Simone I Strasser, et al.
Plos One|July 15, 2011
SHIP-deficient dendritic cells, unlike wild type dendritic cells, suppress T cell proliferation via a nitric oxide-independent mechanismFrann Antignano, Melisa Hamilton, Scott Patterson, et al.
Administration and Policy in Mental Health|March 21, 2023
eHealth Use on Acute Inpatient Mental Health Units: Implementation Processes, Common Practices, and Barriers to UseEmily Bass, Jennifer Garabrant, Michelle P Salyers, et al.
Vaccine|February 9, 2017
Exploratory efficacy endpoints in the Community-Acquired Pneumonia Immunization Trial in Adults (CAPiTA)Chris Webber, Michael Patton, Scott Patterson, et al.
Journal of the Heart Valve Society|August 26, 2025
Extracellular Matrix Dynamics in Aortic Valve Health and Disease: Insights into Fibrocalcific Remodeling and Creation of Biomimetic PlatformsAshley J Scott Patterson, Vaidehi A Patil, Lysmarie Figueroa-Rios, et al.
The Pediatric Infectious Disease Journal|August 6, 2014
Pneumococcal conjugate vaccine-elicited antibody persistence and immunogenicity and safety of 13-valent pneumococcal conjugate vaccine in children previously vaccinated with 4 doses of either 7-valent or 13-valent pneumococcal conjugate vaccineBéatrice Quinet, France Laudat, Alejandra Gurtman, et al.
Journal of Biomedical Informatics|February 25, 2018
Electronic health record case studies to advance environmental public health trackingGonza Namulanda, Judith Qualters, Ambarish Vaidyanathan, et al.
Vaccines|September 28, 2024
Antibody Persistence and Risk of COVID-19 Infection: Insights from ModelingLaurent Coudeville, Eleine Konate, Tabassome Simon, et al.
Vaccine|August 27, 2013
Safety of 13-valent pneumococcal conjugate vaccine in infants and children: meta-analysis of 13 clinical trials in 9 countriesAllison Thompson, Alejandra Gurtman, Scott Patterson, et al.
Pageof 7

Showing results (11-20 of 61) with videos related to

Sort By:
Pageof 7
Human Vaccines & Immunotherapeutics|February 3, 2018
Modeling excess zeroes in an integrated analysis of vaccine safetyRoger Maansson, David Radley, Qin Jiang, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 1, 2013
Combination of lamivudine and adefovir without hepatitis B immune globulin is safe and effective prophylaxis against hepatitis B virus recurrence in hepatitis B surface antigen-positive liver transplant candidatesEdward J Gane, Scott Patterson, Simone I Strasser, et al.
Plos One|July 15, 2011
SHIP-deficient dendritic cells, unlike wild type dendritic cells, suppress T cell proliferation via a nitric oxide-independent mechanismFrann Antignano, Melisa Hamilton, Scott Patterson, et al.
Administration and Policy in Mental Health|March 21, 2023
eHealth Use on Acute Inpatient Mental Health Units: Implementation Processes, Common Practices, and Barriers to UseEmily Bass, Jennifer Garabrant, Michelle P Salyers, et al.
Vaccine|February 9, 2017
Exploratory efficacy endpoints in the Community-Acquired Pneumonia Immunization Trial in Adults (CAPiTA)Chris Webber, Michael Patton, Scott Patterson, et al.
Journal of the Heart Valve Society|August 26, 2025
Extracellular Matrix Dynamics in Aortic Valve Health and Disease: Insights into Fibrocalcific Remodeling and Creation of Biomimetic PlatformsAshley J Scott Patterson, Vaidehi A Patil, Lysmarie Figueroa-Rios, et al.
The Pediatric Infectious Disease Journal|August 6, 2014
Pneumococcal conjugate vaccine-elicited antibody persistence and immunogenicity and safety of 13-valent pneumococcal conjugate vaccine in children previously vaccinated with 4 doses of either 7-valent or 13-valent pneumococcal conjugate vaccineBéatrice Quinet, France Laudat, Alejandra Gurtman, et al.
Journal of Biomedical Informatics|February 25, 2018
Electronic health record case studies to advance environmental public health trackingGonza Namulanda, Judith Qualters, Ambarish Vaidyanathan, et al.
Vaccines|September 28, 2024
Antibody Persistence and Risk of COVID-19 Infection: Insights from ModelingLaurent Coudeville, Eleine Konate, Tabassome Simon, et al.
Vaccine|August 27, 2013
Safety of 13-valent pneumococcal conjugate vaccine in infants and children: meta-analysis of 13 clinical trials in 9 countriesAllison Thompson, Alejandra Gurtman, Scott Patterson, et al.
Pageof 7